Pharmacheck Consulting Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 50.50%
(FY 2022)
- Profit -54.87%
(FY 2022)
- Ebitda 190.88%
(FY 2022)
- Net Worth 29.10%
(FY 2022)
- Total Assets 42.08%
(FY 2022)
About Pharmacheck Consulting Services
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Alysha Vazirally and Irfan Vazirally serve as directors at the Company.
- CIN/LLPIN
U74900KA2016PTC085157
- Company No.
085157
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharmacheck Consulting Services?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Irfan Vazirally  | Managing Director | 08-Jan-2016 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alysha Vazirally | Director | 01-Mar-2019 | Current |
Financial Performance and Corporate Structure Insights of Pharmacheck Consulting Services.
Pharmacheck Consulting Services Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.5% increase. The company also saw a substantial fall in profitability, with a 54.87% decrease in profit. The company's net worth Soared by an impressive increase of 29.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmacheck Consulting Services?
In 2021, Pharmacheck Consulting Services had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmacheck Consulting Services?
Unlock and access historical data on people associated with Pharmacheck Consulting Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmacheck Consulting Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmacheck Consulting Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
